2013

Doctor collaborates with industry to conduct lifesaving, breakthrough research.”  “Doctor educates colleagues about safety and…

OIG recently published a Special Fraud Alert on physician-owned entities that derive revenue from selling, or arranging for the…

A recent survey developed by Global Education Group and Medical Meetings magazine, sought to determine whether attending…

Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) announced…

Two of the most recent settlements involving pharmaceutical companies alleged to have engaged in off-label promotion, included…

In December of last year, we reported on a landmark ruling from the United States Court of Appeals for the Second Circuit (New…

With increased focus on transparency and reporting or monitoring conflicts of interest (COI), there is more and more pressure on…

Eating lunches and feeling guilty is something we are supposed to do when we are older after we have gained some weight.   But now…

Earlier this month, New Jersey-based Par Pharmaceutical Companies Inc. (“Par”) pleaded guilty in federal court agreed to pay $45…

Over the past several years, there has been significant attention drawn the prescription drug abuse and overuse of painkillers or…